Plasma Concentrations of Aminoterminal Pro Atrial Natriuretic Peptide and Aminoterminal Pro Brain Natriuretic Peptide in Healthy Neonates: Marked and Rapid Increase After Birth
- 1 October 2003
- journal article
- research article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 112 (4) , 896-899
- https://doi.org/10.1542/peds.112.4.896
Abstract
Objective. The purpose of the study was to examine the possible age dependency of plasma N-terminal pro atrial natriuretic peptide (N-ANP) and N-terminal pro brain natriuretic peptide (N-BNP) levels in healthy term neonates to establish normal ranges for the neonatal period. Methods. N-ANP and N-BNP plasma concentrations were measured in peripheral venous (n = 116) and umbilical cord blood (n = 37) in 153 healthy term neonates (mean: 5.1; range: 0–30 days) using an enzyme immunoassay. The neonates were classified into 8 groups according to their age (day of delivery and 1, 2, 3, 4, 5–7, 8–14, and 14–30 days of age). Results. The plasma N-ANP and N-BNP concentration were the highest at the first day of age (96 700; 6912–436 000 and 641; 254-1272 fmol/mL) and were found significantly higher compared with the day of delivery (5680; 1005–16 900 and 221; 58–478 fmol/mL; P < 0,0001). After this marked increase, N-ANP and N-BNP levels decreased steadily and became stable at the fifth (5232; 2691–7353 fmol/mL) and third (246; 110–430 fmol/mL) day of life, respectively. Conclusions. The N-ANP and N-BNP plasma concentrations in healthy neonates showed a marked increase during the first days of age, suggesting that ANP and BNP have physiologic roles in the perinatal circulatory change from fetus to neonate.Keywords
This publication has 26 references indexed in Scilit:
- Cardiac peptides differ in their response to exercise. Implications for patients with heart failure in clinical practicePublished by Oxford University Press (OUP) ,1999
- Development of a novel, N-Terminal-proBNP (NT-proBNP) assay with a low detection limitScandinavian Journal of Clinical and Laboratory Investigation, 1999
- Immunoreactive amino‐terminal pro‐brain natriuretic peptide (NT‐PROBNP): a new marker of cardiac impairmentClinical Endocrinology, 1997
- The Amino-Terminal Portion of Pro-Brain Natriuretic Peptide (Pro-BNP) Circulates in Human PlasmaBiochemical and Biophysical Research Communications, 1995
- Accelerated secretion of brain natriuretic peptide from the hypertrophied ventricles in experimental malignant hypertension.Hypertension, 1992
- Brain natriuretic peptide is a novel cardiac hormoneBiochemical and Biophysical Research Communications, 1989
- Increased secretion of atrial natriuretic polypeptide from the left ventricle in patients with dilated cardiomyopathy.Journal of Clinical Investigation, 1989
- Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart.Journal of Clinical Investigation, 1989
- Hemodynamic, renal and endocrine effects of atrial natriuretic peptide infusion in severe heart failureJournal of the American College of Cardiology, 1988
- α-Human atrial natriuretic polypeptide is released from the heart and circulates in the bodyBiochemical and Biophysical Research Communications, 1985